BARD1 and non-small cell lung carcinoma: Notably, the Venn diagram of candidate drivers at the 5 levels showed that BARD1 is present in the results for the 6-level assessment (Fig. 7D), which indicated its potential importance, while Zhang et al. [117] showed that isoforms of BARD1 might be involved in tumor initiation and invasive progression and represent a novel prognostic marker for NSCLC.